Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kaplan

Showing results (781-790 of 893) with videos related to

Pageof 90
Sort By:
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
The Journal of Clinical Investigation|February 23, 2011
A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humansHye Young Kim, María Belén Eyheramonho, Muriel Pichavant, et al.
Human Biology|February 11, 1999
Geographic heterogeneity of 4 common worldwide cystic fibrosis non-DF508 mutations in BrazilS Raskin, J A Phillips, G Kaplan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2023
Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030Angela Y Lam, Jeffrey K Lee, Stephanie Coward, et al.
JMIR Research Protocols|August 1, 2025
Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation StudyKaitlyn Delaney Chappell, Melissa Fox, Thomas Scott Armstrong, et al.
Journal of Medical Economics|July 3, 2026
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysisBelén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2015
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled TrialsJennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, et al.
Digestive Diseases and Sciences|January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness MethodologyGaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Gut|October 21, 2020
Effect of IBD medications on COVID-19 outcomes: results from an international registryRyan C Ungaro, Erica J Brenner, Richard B Gearry, et al.
Pageof 90

Showing results (781-790 of 893) with videos related to

Sort By:
Pageof 90
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
The Journal of Clinical Investigation|February 23, 2011
A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humansHye Young Kim, María Belén Eyheramonho, Muriel Pichavant, et al.
Human Biology|February 11, 1999
Geographic heterogeneity of 4 common worldwide cystic fibrosis non-DF508 mutations in BrazilS Raskin, J A Phillips, G Kaplan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2023
Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030Angela Y Lam, Jeffrey K Lee, Stephanie Coward, et al.
JMIR Research Protocols|August 1, 2025
Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation StudyKaitlyn Delaney Chappell, Melissa Fox, Thomas Scott Armstrong, et al.
Journal of Medical Economics|July 3, 2026
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysisBelén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2015
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled TrialsJennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, et al.
Digestive Diseases and Sciences|January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness MethodologyGaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Gut|October 21, 2020
Effect of IBD medications on COVID-19 outcomes: results from an international registryRyan C Ungaro, Erica J Brenner, Richard B Gearry, et al.
Pageof 90